Le Lézard
Classified in: Health
Subject: SVY

Global Sports Medicine Market (2018-2024) Projected to Exhibit a CAGR of 7.5%


DUBLIN, July 13, 2018 /PRNewswire/ --

The "Global Sports Medicine Market - Technologies, Market share and Industry Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Global sports medicine market is anticipated to grow with a CAGR of 7.5% during forecast period (2017-2024).

Sport medicine products help individuals to recover or treat injuries. Moreover, sports medicine has exhibited a substantial growth in the healthcare field.

The major driving factors of the sports medicine market are growing incidence of sports injuries, developments in the field of regenerative medicine, government contribution in encouraging sports activities and increasing minimally invasive surgeries. In addition, the major opportunities of the market are technological development in sports medicine and investment in sports medicine.

The major restraining factors of the market are high cost of orthopaedic implants and lack of appropriate reimbursement to the sport-related injuries.

Based on the segmentation, global sports medicine market is segmented into product and application. The product segment is further segmented into body reconstruction and repair (surgical equipment, soft tissue repair, bone reconstruction devices), body support and recovery (braces and other support devices, compression clothing, hot and cold therapy), body monitoring and evaluation (cardiac, respiratory, hemodynamic, musculoskeletal, others), and accessories (disinfectants, tapes, bandages, wraps, other accessories). Moreover, application segment includes knees, shoulders, ankle & foot, back & spine, elbow & wrist, hip and other applications market.

In 2017, the knee injuries segment of application segment is projected to hold the largest share of the sports medicine market. Development in the knee injuries segment can be accredited to the growing contribution in sports like basketball and football at a younger age, ensuring high occurrence of knee injuries.

Geographically, global sports medicine market is segmented into North America (U.S. & Canada), Asia Pacific (China, India, Japan, RoAPAC), Europe (UK, France, Germany, RoE) and Rest of World.

North America accounted for the highest revenue share in 2017 due to the augmented popularity of physical & sports activities, investments in the field of sports awareness, continuous government support and exertions to increase awareness on the treatment & prevention of sports injuries.

Moreover, Asia Pacific is anticipated to be the fastest growing region during the forecast period (2017-2024). The growth is attributed to the invasion of international players, government initiatives to encourage sports medicine and collaborations for sports medicine research, which are some of the main factors increasing market growth in Asia Pacific.

Some of the major players of the market are Arthrex (US), Arthrocare (US), DJO Global (US), Johnson & Johnson (Depuy Synthes) (US), Medtronic (US), Mueller Sports Medicine Inc. (US) and others.

Companies Featured

Key Topics Covered

1.Introduction
1.1.Executive Summary
1.2.Estimation Methodology

2.Market Overview
2.1.Global Sports Medicine Market: Evolution & Transition
2.2.Market Definition & Scope
2.3.Industry Structure
2.4.Regulatory Framework
2.5.Total Market Analysis
2.5.1.Top 5 Findings
2.5.2.Top 5 Opportunity Markets
2.5.3.Top 5 Companies
2.5.4.Top 3 Competitive Strategies
2.6.Estimation Analysis
2.7.Strategic Analysis
2.7.1.Investment Vs. Adoption Model
2.7.2.360-Degree Industry Analysis
2.7.3.Porters 5 Force Model
2.7.4.See-Saw Analysis
2.7.5.Consumer Analysis And Key Buying Criteria
2.8.Competitive Analysis
2.8.1.Key Strategies & Analysis
2.8.2.Market Share Analysis & Top Company Analysis
2.9.Strategic Recommendations & Key Conclusions
2.9.1.Investment Opportunities By Regions
2.9.2.Opportunities In Emerging Applications
2.9.3.Investment Opportunity In Fastest Growing Segment

3.Market Determinants
3.1.Market Drivers
3.1.1.Growing Incidence Of Sports Injuries
3.1.2.Government Contribution In Encouraging Sports Activities
3.1.3.Developments In The Field Of Regenerative Medicine
3.1.4.Increasing Minimally Invasive Surgeries
3.2.Market Restraints
3.2.1.Lack Of Appropriate Reimbursement To Sport-Related Injuries
3.2.2.High Cost Of Orthopedic Implants
3.3.Market Opportunities
3.3.1.Technological Development In Sports Medicine
3.3.2.Investment In Sports Medicine
3.4. Market Challenges
3.4.1.Lack Of Skilled Professionals

4.Global Sports Medicine Market By Product
4.1.Market Definition And Scope
4.2.Decision Support Database & Estimation Methodology
4.3.Comparative Analysis Across Market Segments
4.4.Opportunity Matrix
4.5.Market Segmentation
4.5.1.Global Body Reconstruction And Repair Market
4.5.1.1.Adoption Scenario & Market Determinants
4.5.1.2.Market Estimations And Forecasts 2015-2024 ($ Million)
4.5.1.3.Key Players & Key Products
4.5.1.4.Key Conclusions
4.5.1.5.Sub-Segments
4.5.1.5.1.Surgical Equipment
4.5.1.5.2.Soft Tissue Repair
4.5.1.5.3.Bone Reconstruction Devices
4.5.2.Global Body Support And Recovery Market
4.5.2.1.Adoption Scenario & Market Determinants
4.5.2.2.Market Estimations And Forecasts 2015-2024 ($ Million)
4.5.2.3.Key Players & Key Products
4.5.2.4.Key Conclusions
4.5.2.5.Sub-Segments
4.5.2.5.1.Braces And Other Support Devices
4.5.2.5.2.Compression Clothing
4.5.2.5.3.Hot And Cold Therapy
4.5.3.Global Body Monitoring And Evaluation Market
4.5.3.1.Adoption Scenario & Market Determinants
4.5.3.2.Market Estimations And Forecasts 2015-2024 ($ Million)
4.5.3.3.Key Players & Key Products
4.5.3.4.Key Conclusions
4.5.3.5.Sub-Segments
4.5.3.5.1.Cardiac
4.5.3.5.2.Respiratory
4.5.3.5.3.Hemodynamic
4.5.3.5.4.Musculoskeletal
4.5.3.5.5.Others
4.5.4.Global Accessories Market
4.5.4.1.Adoption Scenario & Market Determinants
4.5.4.2.Market Estimations And Forecasts 2015-2024 ($ Million)
4.5.4.3.Key Players & Key Products
4.5.4.4.Key Conclusions
4.5.4.5.Sub-Segments
4.5.4.5.1.Disinfectants
4.5.4.5.2.Tapes
4.5.4.5.3.Bandages
4.5.4.5.4.Wraps
4.5.4.5.5.Other Accessories

5.Global Sports Medicine Market By Application
5.1.Market Definition And Scope
5.2.Decision Support Database & Estimation Methodology
5.3.Comparative Analysis Across Market Segments
5.4.Opportunity Matrix
5.5.Market Segmentation
5.5.1. Global Knees Market
5.5.1.1.Adoption Scenario & Market Determinants
5.5.1.2.Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.1.3.Key Players & Key Products
5.5.1.4.Key Conclusions
5.5.2.Global Shoulders Market
5.5.2.1.Adoption Scenario & Market Determinants
5.5.2.2.Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.2.3.Key Players & Key Products
5.5.2.4.Key Conclusions
5.5.3. Global Ankle & Foot Market
5.5.3.1.Adoption Scenario & Market Determinants
5.5.3.2.Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.3.3.Key Players & Key Products
5.5.3.4.Key Conclusions
5.5.4. Global Back & Spine Market
5.5.4.1.Adoption Scenario & Market Determinants
5.5.4.2.Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.4.3.Key Players & Key Products
5.5.4.4.Key Conclusions
5.5.5. Global Elbow & Wrist Market
5.5.5.1.Adoption Scenario & Market Determinants
5.5.5.2.Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.5.3.Key Players & Key Products
5.5.5.4.Key Conclusions
5.5.6. Global Hip Market
5.5.6.1.Adoption Scenario & Market Determinants
5.5.6.2.Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.6.3.Key Players & Key Products
5.5.6.4.Key Conclusions
5.5.7. Global Others Market
5.5.7.1.Adoption Scenario & Market Determinants
5.5.7.2.Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.7.3.Key Players & Key Products
5.5.7.4.Key Conclusions

6.Competitive Landscape
6.1.Key Strategies
6.1.1.List Of Mergers And Acquisitions
6.1.2.List Of Joint Ventures
6.1.3.List Of Product Launches
6.1.4.List Of Partnerships

7.Geographic Analysis
7.1.Decision Support Database & Estimation Methodology
7.2.Comparative Analysis Across Market Segments
7.3.Opportunity Matrix
7.4. Global Sports Medicine Market By Region 2015-2024 ($ Million)
7.4.1.North America
7.4.1.1.Industry Analysis 2015-2024 ($ Million)
7.4.1.2.Top Country Analysis
7.4.1.2.1.U.S.
7.4.1.2.1.1.Market Estimations And Forecasts 2015-2024 ($ Million)
7.4.1.2.1.2.Key Players & Key Products
7.4.1.2.1.3.Key Conclusions
7.4.1.2.2.Canada
7.4.1.2.2.1.Market Estimations And Forecasts 2015-2024 ($ Million)
7.4.1.2.2.2.Key Players & Key Products
7.4.1.2.2.3.Key Conclusions
7.4.2.Europe
7.4.2.1.Industry Analysis 2015-2024 ($ Million)
7.4.2.2.Top Country Analysis
7.4.2.2.1.UK
7.4.2.2.1.1.Market Estimations And Forecasts 2015-2024 ($ Million)
7.4.2.2.1.2.Key Players & Key Products
7.4.2.2.1.3.Key Conclusions
7.4.2.2.2.France
7.4.2.2.2.1.Market Estimations And Forecasts 2015-2024 ($ Million)
7.4.2.2.2.2.Key Players & Key Products
7.4.2.2.2.3.Key Conclusions
7.4.2.2.3.Germany
7.4.2.2.3.1.Market Estimations And Forecasts 2015-2024 ($ Million)
7.4.2.2.3.2.Key Players & Key Products
7.4.2.2.3.3.Key Conclusions
7.4.2.2.4.Spain
7.4.2.2.4.1.Market Estimations And Forecasts 2015-2024 ($ Million)
7.4.2.2.4.2.Key Players & Key Products
7.4.2.2.4.3.Key Conclusions
7.4.2.2.5.Rest Of Europe
7.4.2.2.5.1.Market Estimations And Forecasts 2015-2024 ($ Million)
7.4.2.2.5.2.Key Players & Key Products
7.4.2.2.5.3.Key Conclusions
7.4.3.Asia Pacific
7.4.3.1.Industry Analysis 2015-2024 ($ Million)
7.4.3.2.Top Country Analysis
7.4.3.2.1.China
7.4.3.2.1.1.Market Estimations And Forecasts 2015-2024 ($ Million)
7.4.3.2.1.2.Key Players & Key Products
7.4.3.2.1.3.Key Conclusions
7.4.3.2.2.India
7.4.3.2.2.1.Market Estimations And Forecasts 2015-2024 ($ Million)
7.4.3.2.2.2.Key Players & Key Products
7.4.3.2.2.3.Key Conclusions
7.4.3.2.3.Japan
7.4.3.2.3.1.Market Estimations And Forecasts 2015-2024 ($ Million)
7.4.3.2.3.2.Key Players & Key Products
7.4.3.2.3.3.Key Conclusions
7.4.3.2.4.Australia
7.4.3.2.4.1.Market Estimations And Forecasts 2015-2024 ($ Million)
7.4.3.2.4.2.Key Players & Key Products
7.4.3.2.4.3.Key Conclusions
7.4.3.2.5.Rest Of Asia Pacific
7.4.3.2.5.1.Market Estimations And Forecasts 2015-2024 ($ Million)
7.4.3.2.5.2.Key Players & Key Products
7.4.3.2.5.3.Key Conclusions
7.4.4.Row
7.4.4.1.Industry Analysis 2015-2024 ($ Million)
7.4.4.2.Top Country Analysis
7.4.4.2.1.Latin America
7.4.4.2.1.1.Market Estimations And Forecasts 2015-2024 ($ Million)
7.4.4.2.1.2.Key Players & Key Products
7.4.4.2.1.3.Key Conclusions
7.4.4.2.2.Middle East & Africa
7.4.4.2.2.1.Market Estimations And Forecasts 2015-2024 ($ Million)
7.4.4.2.2.2.Key Players & Key Products
7.4.4.2.2.3.Key Conclusions

8.Company Profiles
8.1.Arthrex (US)
8.1.1.Overview
8.1.2.Product Portfolio
8.1.3.Strategic Initiatives
8.1.4.Scot Analysis
8.1.5.Strategic Analysis
8.2.Arthrocare (US)
8.2.1.Overview
8.2.2.Product Portfolio
8.2.3.Strategic Initiatives
8.2.4.Scot Analysis
8.2.5.Strategic Analysis
8.3.Breg Inc. (US)
8.3.1.Overview
8.3.2.Product Portfolio
8.3.3.Strategic Initiatives
8.3.4.Scot Analysis
8.3.5.Strategic Analysis
8.4.Conmed Corporation (Linvatec Corporation) (US)
8.4.1.Overview
8.4.2.Product Portfolio
8.4.3.Strategic Initiatives
8.4.4.Scot Analysis
8.4.5.Strategic Analysis
8.5.DJO Global (US)
8.5.1.Overview
8.5.2.Product Portfolio
8.5.3.Strategic Initiatives
8.5.4.Scot Analysis
8.5.5.Strategic Analysis
8.6.Johnson & Johnson (Depuy Synthes) (US)
8.6.1.Overview
8.6.2.Product Portfolio
8.6.3.Strategic Initiatives
8.6.4.Scot Analysis
8.6.5.Strategic Analysis
8.7.Medtronic (US)
8.7.1.Overview
8.7.2.Product Portfolio
8.7.3.Strategic Initiatives
8.7.4.Scot Analysis
8.7.5.Strategic Analysis
8.8.Mueller Sports Medicine Inc. (US)
8.8.1.Overview
8.8.2.Product Portfolio
8.8.3.Strategic Initiatives
8.8.4.Scot Analysis
8.8.5.Strategic Analysis
8.9.Ossur Hf (Iceland)
8.9.1.Overview
8.9.2.Product Portfolio
8.9.3.Strategic Initiatives
8.9.4.Scot Analysis
8.9.5.Strategic Analysis
8.10.Otto Bock Healthcare (India)
8.10.1.Overview
8.10.2.Product Portfolio
8.10.3.Strategic Initiatives
8.10.4.Scot Analysis
8.10.5.Strategic Analysis
8.11.RTI Surgical (US)
8.11.1.Overview
8.11.2.Product Portfolio
8.11.3.Strategic Initiatives
8.11.4.Scot Analysis
8.11.5.Strategic Analysis
8.12.Smith & Nephew Plc (US)
8.12.1.Overview
8.12.2.Product Portfolio
8.12.3.Strategic Initiatives
8.12.4.Scot Analysis
8.12.5.Strategic Analysis
8.13.Stryker Corporation (US)
8.13.1.Overview
8.13.2.Product Portfolio
8.13.3.Strategic Initiatives
8.13.4.Scot Analysis
8.13.5.Strategic Analysis
8.14.Wright Medical Group (US)
8.14.1.Overview
8.14.2.Product Portfolio
8.14.3.Strategic Initiatives
8.14.4.Scot Analysis
8.14.5.Strategic Analysis
8.15.Zimmer Biomet (US)
8.15.1.Overview
8.15.2.Product Portfolio
8.15.3.Strategic Initiatives
8.15.4.Scot Analysis
8.15.5.Strategic Analysis

For more information about this report visit https://www.researchandmarkets.com/research/qnsrf3/global_sports?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:


Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 03:05
MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical Study with MH002
MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today reports positive topline results from its Phase 2a clinical trial with MH002 in the orphan disease...

at 03:00
Beckman Coulter's DxI 9000 Immunoassay Analyzer Extends Menu with New CE-Marked Hepatitis Assays at ESCMID Global
Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global), that it has extended the menu of DxI 9000 Immunoassay...

at 03:00
Viewpoint Collaborates with Medical Aid International to Spotlight Healthcare Transformation in LMICs
Viewpoint, the esteemed educational program hosted by distinguished actor Dennis Quaid, is pleased to announce a collaborative effort with Medical Aid International for an upcoming episode dedicated to transforming healthcare in Low and Middle Income...

at 02:35
SpikImm Announces the Signature of an Exclusive License Option and Collaboration Agreement With SATT Conectus for the Development of a Prophylactic Treatment Against the BK Virus, Causing Severe Complications in Transplant Patients
SpikImm, a clinical-stage biotechnology company founded in 2021 by Truffle Capital in collaboration with Institut Pasteur and dedicated to the development of monoclonal antibodies to prevent viral infections in immunocompromised patients, today...

at 02:00
SSI Schaefer & Noatum Logistics: Success of the Largest Mobile Racking System Installation for Cold Rooms in the UAE
SSI Schaefer, a global leader in warehouse automation and cold-chain storage solutions, is announcing the results of its partnership with Noatum Logistics Middle East, an integrated regional end-to-end logistics services arm of Noatum, an AD...

at 01:48
Korea Zinc announces non-renewal of sulfuric acid consignment contract with Young Poong
The consignment of sulfuric acid originated from Young Poong's Seokpo Smelter adds to the operational risks for Korea Zinc Young Poong has passed the costs and risks associated with sulfuric acid management to Korea Zinc while backlash from the local...

More news about Health...


News published on and distributed by: